{"DataElement":{"publicId":"4024971","version":"1","preferredName":"Molecular Neoplasm Profile Test Clinical Benefits Prediction Affected Integer::3 Point Likert Scale","preferredDefinition":"The 3 point Likert scale response regarding whether there was any impact on decision to request molecular tumor profiling tests based on prediction of clinical benefits from specific treatments.","longName":"MNPT_BEN_PR_AF_3_LIK","context":"LCC","contextVersion":"1","DataElementConcept":{"publicId":"4024787","version":"1","preferredName":"Molecular Neoplasm Profile Test Clinical Benefits Prediction","preferredDefinition":"Molecular; relating to or produced by or consisting of molecules._A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias._An analysis (often in graphical form) representing the extent to which something exhibits various characteristics._A procedure for critical evaluation; a means of determining the presence, quality, or truth of something._Relating to the examination and treatment of patients dependent on direct observation.  The term may also refer to the institution (clinic) providing this activity._The positive effects of something._An extrapolation of given data into the future.","longName":"MNP_TST_CLI_BEN_PRE","context":"LCC","contextVersion":"1","ObjectClass":{"publicId":"4024763","version":"1","preferredName":"Molecular Neoplasm Profile Test","preferredDefinition":"Molecular; relating to or produced by or consisting of molecules.:A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.:An analysis (often in graphical form) representing the extent to which something exhibits various characteristics.:A procedure for critical evaluation; a means of determining the presence, quality, or truth of something.","longName":"C25574:C3262:C84385:C47891","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Molecular","conceptCode":"C25574","definition":"Relating to or produced by or consisting of molecules.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Profile","conceptCode":"C84385","definition":"An analysis (often in graphical form) representing the extent to which something exhibits various characteristics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Test","conceptCode":"C47891","definition":"A procedure for critical evaluation; a means of determining the presence, quality, or truth of something.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"EDE9F5C2-EAB1-A461-E040-BB89AD43353E","latestVersionIndicator":"Yes","beginDate":"2013-12-19","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2013-12-19","modifiedBy":"ONEDATA","dateModified":"2013-12-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"4024785","version":"1","preferredName":"Clinical Benefits Prediction","preferredDefinition":"Relating to the examination and treatment of patients dependent on direct observation. The term may also refer to the institution (clinic) providing this activity.:The positive effects of something.:An extrapolation of given data into the future.","longName":"C25398:C25387:C54156","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Clinical","conceptCode":"C25398","definition":"Relating to the examination and treatment of patients dependent on direct observation.  The term may also refer to the institution (clinic) providing this activity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Benefit","conceptCode":"C25387","definition":"The positive effects of something.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Prediction","conceptCode":"C54156","definition":"An extrapolation of given data into the future.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"EDEA3275-DF30-1839-E040-BB89AD430288","latestVersionIndicator":"Yes","beginDate":"2013-12-19","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2013-12-19","modifiedBy":"ONEDATA","dateModified":"2013-12-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2524082","version":"1","preferredName":"Person Measure/Instrument Testing","preferredDefinition":"Process and results associated with self-reported measures and instruments, surveys, other tools","longName":"MEASURE/INSTRUMENT TESTING","context":"CCR","contextVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"1E838B40-6636-0A25-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-09-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-09-28","modifiedBy":"REEVESD","dateModified":"2008-11-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"EDEA3275-DF41-1839-E040-BB89AD430288","latestVersionIndicator":"Yes","beginDate":"2013-12-19","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2013-12-19","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":"Molecular Tumor Profile. LCC. ghd. 12.19.13","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"4011972","version":"1","preferredName":"Affected Integer::3 Point Likert Scale","preferredDefinition":"To be influenced by or changed._A number with no fractional part, including the negative and positive numbers as well as zero.::3_The precise location of something; a spatially limited location._A psychometric scale commonly used in questionnaires where a respondent is asked to evaluate an opinion according to subjective or objective criteria, by rating their level of agreement or disagreement with a statement._an ordered reference standard.","longName":"AFF_3PT_LKT_SCA","context":"LCC","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"1","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"3","valueDescription":"High impact","ValueMeaning":{"publicId":"4011973","version":"1","preferredName":"High impact","longName":"4011973","preferredDefinition":"High impact","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"EDB12BD8-7026-DCD7-E040-BB89AD4338AF","latestVersionIndicator":"Yes","beginDate":"2013-12-16","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2013-12-16","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EDB12BD8-703F-DCD7-E040-BB89AD4338AF","beginDate":"2013-12-16","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2013-12-16","modifiedBy":"ONEDATA","dateModified":"2013-12-16","deletedIndicator":"No"},{"value":"2","valueDescription":"Moderate impact","ValueMeaning":{"publicId":"4011974","version":"1","preferredName":"Moderate impact","longName":"4011974","preferredDefinition":"Moderate impact","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"EDB12BD8-7049-DCD7-E040-BB89AD4338AF","latestVersionIndicator":"Yes","beginDate":"2013-12-16","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2013-12-16","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EDB12BD8-7062-DCD7-E040-BB89AD4338AF","beginDate":"2013-12-16","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2013-12-16","modifiedBy":"ONEDATA","dateModified":"2013-12-16","deletedIndicator":"No"},{"value":"1","valueDescription":"Little or no impact","ValueMeaning":{"publicId":"4011975","version":"1","preferredName":"Little or no impact","longName":"4011975","preferredDefinition":"Little or no impact","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"EDB12BD8-706C-DCD7-E040-BB89AD4338AF","latestVersionIndicator":"Yes","beginDate":"2013-12-16","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2013-12-16","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EDB12BD8-7085-DCD7-E040-BB89AD4338AF","beginDate":"2013-12-16","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2013-12-16","modifiedBy":"ONEDATA","dateModified":"2013-12-16","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2524082","version":"1","preferredName":"Person Measure/Instrument Testing","preferredDefinition":"Process and results associated with self-reported measures and instruments, surveys, other tools","longName":"MEASURE/INSTRUMENT TESTING","context":"CCR","contextVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"1E838B40-6636-0A25-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-09-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-09-28","modifiedBy":"REEVESD","dateModified":"2008-11-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"4011971","version":"1","preferredName":"Affected Integer::3 Point Likert Scale Scale","preferredDefinition":"To be influenced by or changed.\r\n:A number with no fractional part, including the negative and positive numbers as well as zero.::3:The precise location of something; a spatially limited location.:A psychometric scale commonly used in questionnaires where a respondent is asked to evaluate an opinion according to subjective or objective criteria, by rating their level of agreement or disagreement with a statement.:an ordered reference standard.","longName":"4011971v1.0","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Affected","conceptCode":"C64917","definition":"To be influenced by or changed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Integer","conceptCode":"C45255","definition":"A number with no fractional part, including the negative and positive numbers as well as zero.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Point","conceptCode":"C70656","definition":"The precise location of something; a spatially limited location.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Likert Scale","conceptCode":"C85429","definition":"A psychometric scale commonly used in questionnaires where a respondent is asked to evaluate an opinion according to subjective or objective criteria, by rating their level of agreement or disagreement with a statement.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Scale","conceptCode":"C25664","definition":"An ordered reference standard used to measure incremental changes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"EDB12BD8-7001-DCD7-E040-BB89AD4338AF","latestVersionIndicator":"Yes","beginDate":"2013-12-16","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2013-12-16","modifiedBy":"ONEDATA","dateModified":"2013-12-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"EDB12BD8-7012-DCD7-E040-BB89AD4338AF","latestVersionIndicator":"Yes","beginDate":"2013-12-16","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2013-12-16","modifiedBy":"HARTLEYG","dateModified":"2013-12-20","changeDescription":"LCC_MolTumProf_ghd_12.16.13","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"Test predicts clinical benefi","type":"Preferred Question Text","description":"Test predicts clinical benefit from specific treatments","url":null,"context":"LCC"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"EDEB579A-4E86-EA43-E040-BB89AD437984","latestVersionIndicator":"Yes","beginDate":"2013-12-19","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2013-12-19","modifiedBy":"HARTLEYG","dateModified":"2013-12-20","changeDescription":"Molecular Tumor Profiling Tests_LCC_ghd_12.19.13","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}